From Staff
A Brownstone Journal
article alleges that federal health officials understated the volume
of vaccine injury reports during the early COVID-19 vaccine rollout.
The claims raise questions about data processing, public
communication and the limitations of vaccine safety monitoring.
The U.S. Centers for
Disease Control and Prevention (CDC) is facing renewed scrutiny over
its handling of early COVID-19 vaccine safety data following
allegations that the agency reassured the public while its reporting
contractor struggled to process a surge in adverse-event reports.
In an October 28
article titled “How the CDC Lied about Shot Injury,” Jeffrey A.
Tucker of the Brownstone Journal argues that federal officials failed
to adequately disclose the backlog affecting the Vaccine Adverse
Event Reporting System (VAERS) during the initial months of the
COVID-19 vaccination campaign.
The article focuses
on a January 15, 2021, memo from General Dynamics Information
Technology (GDIT), the contractor responsible for processing VAERS
reports. According to the memo quoted by Tucker, incoming COVID-19
vaccine reports had significantly exceeded the anticipated maximum of
1,000 reports per day, preventing the contractor from meeting
established processing and response timeframes.
Tucker argues that
the warning should have prompted an immediate reassessment of the
vaccination campaign and more cautious public statements about
vaccine safety.
On February 19,
2021, the CDC published an early assessment of COVID-19 vaccine
safety in its Morbidity and Mortality Weekly Report (MMWR).
The report examined
6,994 VAERS reports received between December 14, 2020, and January
13, 2021. Its authors described the initial safety findings as
reassuring and reported no unexpected patterns of serious adverse
events.
Tucker contends that
the assessment provided an incomplete picture because the number of
reports discussed in the publication was substantially lower than the
total number of reports he says had accumulated by that time.
He argues that the
public-facing conclusions did not adequately communicate the
implications of the processing backlog or the limitations of the
available data.
However, the
distinction between reports received and reports processed is
critical. VAERS data undergo processing and review, and the number of
reports analyzed in a published assessment does not, by itself,
establish that officials concealed injuries or knowingly
misrepresented vaccine safety. Establishing deliberate deception
would require additional evidence concerning what officials knew,
when they knew it and how they interpreted the available information.
The Brownstone
Journal article also challenges the CDC's reporting of serious
adverse events and deaths.
According to Tucker,
approximately 9.2% of the reports examined in the early assessment
were classified as serious. He uses that percentage to argue that
thousands of serious events may have been represented in the larger
pool of reports.
The article further
cites approximately 966 death reports in VAERS by mid-February 2021,
contrasting that figure with the 113 deaths discussed in the CDC
assessment. The CDC report stated that available information did not
suggest a causal relationship between vaccination and those deaths.
These figures
require careful interpretation. VAERS is a passive surveillance
system that accepts reports of health events occurring after
vaccination, including events that may be coincidental or unrelated
to the vaccine. A report is not, by itself, proof that a vaccine
caused an injury or death.
Likewise, a report's
classification as serious does not establish causation. Determining
whether a vaccine caused a particular outcome requires further
clinical and epidemiological assessment.
Nevertheless, the
scale of incoming reports and the ability of surveillance systems to
process them promptly are legitimate subjects for public scrutiny.
VAERS was designed
to identify potential vaccine safety signals, not to independently
establish the frequency of vaccine injuries or prove causation. The
system can receive reports from healthcare professionals,
manufacturers and members of the public, and its data can contain
incomplete information, duplicate submissions and unverified claims.
Public health
authorities have also acknowledged that passive reporting systems may
capture only a fraction of adverse events.
Tucker argues that
this limitation makes the reported figures an incomplete measure of
the potential harm associated with COVID-19 vaccination. He also
contends that the CDC's reassuring public statements failed to convey
sufficient uncertainty during the rollout.
The broader issue is
whether the agency communicated the limitations of its surveillance
systems clearly enough while evidence was still emerging. That
question is distinct from whether the available reports establish the
article's allegations of deliberate deception.
The article raises
concerns about the relationship between the CDC, its contractors and
the pharmaceutical companies that developed COVID-19 vaccines. It
also criticizes the legal protections afforded to manufacturers under
the emergency public health framework.
During the pandemic,
the Public Readiness and Emergency Preparedness (PREP) Act provided
significant liability protections for covered countermeasures,
subject to statutory conditions and exceptions. Emergency Use
Authorization (EUA), meanwhile, allowed the Food and Drug
Administration to authorize certain medical products during a
declared emergency under a separate legal framework. These mechanisms
did not eliminate all regulatory requirements.
Tucker argues that
the combination of limited liability, vaccine mandates and public
assurances created an environment in which potential safety concerns
did not receive sufficient attention.
His article calls
for accountability and renewed examination of the records surrounding
the early vaccine rollout. However, the claims that officials
deliberately lied, that the contractor's backlog proves widespread
vaccine-caused injury, or that the reported deaths were caused by
vaccination require independent corroboration.
The allegations
underscore several questions that warrant examination: How quickly
were incoming VAERS reports processed in early 2021? What did CDC
officials know about the backlog when they issued public safety
assessments? Were the limitations of the available data adequately
disclosed? And did subsequent analyses identify safety signals that
required changes in public health guidance?
Answering these
questions requires examination of the original GDIT memo,
contemporaneous processing records, the complete CDC report, internal
agency communications and independent safety studies.
The early COVID-19
vaccine rollout unfolded under extraordinary public health pressures,
with officials balancing the urgent need to reduce severe disease
against the need to monitor products introduced at unprecedented
speed.
Whether the CDC's
early communications adequately reflected the uncertainty of that
period remains an important question. Determining whether those
communications amounted to deliberate deception, however, requires
evidence beyond a reporting backlog or the number of adverse event
reports alone.
Sources:
How the CDC Lied about Shot Injury
https://brownstone.org/articles/how-the-cdc-lied-about-shot-injury/
The Medical and Ethical Atrocity of “Perioperative Vaccination”
https://brownstone.org/articles/the-medical-and-ethical-atrocity-of-perioperative-vaccination/
Equity with Accountability in Pandemic Preparedness
https://brownstone.org/articles/equity-with-accountability-in-pandemic-preparedness/
